These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27373317)

  • 1. Management of impulse control disorders in Parkinson's disease.
    Zhang S; Dissanayaka NN; Dawson A; O'Sullivan JD; Mosley P; Hall W; Carter A
    Int Psychogeriatr; 2016 Oct; 28(10):1597-614. PubMed ID: 27373317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Impulse Control Disorders with Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.
    Amstutz D; Paschen S; Lachenmayer ML; Maradan-Gachet ME; Deuschl G; Krack P; Debove I
    CNS Neurol Disord Drug Targets; 2020; 19(8):611-617. PubMed ID: 32691720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease management and impulse control disorders: current state and future perspectives.
    Vitale C; Amboni M; Erro R; Picillo M; Pellecchia MT; Barone P; Trojano L; Santangelo G
    Expert Rev Neurother; 2019 Jun; 19(6):495-508. PubMed ID: 31148487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Predictors and modifiers of impulse control disorders in Parkinson`s disease].
    Sapronova MR; Shnayder NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):145-156. PubMed ID: 28635753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.
    Samuel M; Rodriguez-Oroz M; Antonini A; Brotchie JM; Ray Chaudhuri K; Brown RG; Galpern WR; Nirenberg MJ; Okun MS; Lang AE
    Mov Disord; 2015 Feb; 30(2):150-9. PubMed ID: 25607799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of impulse control disorders with deep brain stimulation: A double-edged sword.
    Kasemsuk C; Oyama G; Hattori N
    J Neurol Sci; 2017 Mar; 374():63-68. PubMed ID: 28126343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.
    Ramirez-Zamora A; Gee L; Boyd J; Biller J
    Expert Rev Neurother; 2016; 16(4):389-99. PubMed ID: 26923084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management.
    Wu K; Politis M; Piccini P
    Postgrad Med J; 2009 Nov; 85(1009):590-6. PubMed ID: 19892894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and impulse control disorders in Parkinson's disease.
    Weintraub D
    Ann Neurol; 2008 Dec; 64 Suppl 2(Suppl 2):S93-100. PubMed ID: 19127573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].
    Sáez-Francàs N; Martí Andrés G; Ramírez N; de Fàbregues O; Álvarez-Sabín J; Casas M; Hernández-Vara J
    Neurologia; 2016 May; 31(4):231-8. PubMed ID: 26096669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus.
    Debove I; Paschen S; Amstutz D; Cardoso F; Corvol JC; Fung VSC; Lang AE; Martinez Martin P; Rodríguez-Oroz MC; Weintraub D; Krack P; Deuschl G;
    Mov Disord; 2024 Feb; 39(2):235-248. PubMed ID: 38234035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in impulse control behaviours of Parkinson's disease.
    Zurowski M; O'Brien JD
    Curr Opin Neurol; 2015 Aug; 28(4):387-92. PubMed ID: 26110803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review.
    Béreau M; Fleury V; Bouthour W; Castrioto A; Lhommée E; Krack P
    Rev Neurol (Paris); 2018 Nov; 174(9):653-663. PubMed ID: 30224159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist.
    Vargas AP; Vaz LS; Reuter A; Couto CM; Costa Cardoso FE
    Parkinsonism Relat Disord; 2019 Nov; 68():17-21. PubMed ID: 31621612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonist withdrawal syndrome: A comprehensive review.
    Yu XX; Fernandez HH
    J Neurol Sci; 2017 Mar; 374():53-55. PubMed ID: 28104232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulse control disorders in Parkinson's disease: a psychosocial perspective.
    Delaney M; Leroi I; Simpson J; Overton PG
    J Clin Psychol Med Settings; 2012 Sep; 19(3):338-46. PubMed ID: 22581074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
    Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.